ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 146 filers reported holding ITEOS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,268,457 | -20.4% | 207,165 | -3.8% | 0.00% | 0.0% |
| Q2 2023 | $2,851,460 | -64.4% | 215,367 | -63.4% | 0.00% | -50.0% |
| Q1 2023 | $8,010,314 | -32.6% | 588,561 | -3.3% | 0.00% | -33.3% |
| Q4 2022 | $11,885,957 | +14.4% | 608,600 | +11.6% | 0.00% | 0.0% |
| Q3 2022 | $10,386,000 | -0.5% | 545,179 | +7.6% | 0.00% | 0.0% |
| Q2 2022 | $10,437,000 | +159.4% | 506,630 | +305.2% | 0.00% | +200.0% |
| Q1 2022 | $4,024,000 | +84.0% | 125,023 | +166.2% | 0.00% | 0.0% |
| Q4 2021 | $2,187,000 | +946.4% | 46,967 | +506.5% | 0.00% | – |
| Q3 2021 | $209,000 | – | 7,744 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 3,706,663 | $126,694,000 | 24.48% |
| MPM BioImpact LLC | 2,355,557 | $80,513,000 | 10.12% |
| Boxer Capital, LLC | 4,345,016 | $148,513,000 | 5.04% |
| RA Capital Management | 4,417,258 | $150,982,000 | 2.28% |
| Ally Bridge Group (NY) LLC | 322,794 | $11,033,000 | 2.12% |
| Asymmetry Capital Management, L.P. | 102,286 | $3,496,000 | 1.81% |
| RTW INVESTMENTS, LP | 2,762,791 | $94,432,000 | 1.47% |
| COWEN AND COMPANY, LLC | 588,238 | $20,106,000 | 1.38% |
| Artal Group S.A. | 1,094,047 | $37,395,000 | 0.66% |
| HighVista Strategies LLC | 19,804 | $677,000 | 0.50% |